会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • 페닐아마이드 화합물을 유효성분으로 하는 고지혈증 치료용 복합 생약 추출물
    • 用于治疗高脂血症的复杂提取物
    • KR1020130025422A
    • 2013-03-11
    • KR1020130010581
    • 2013-01-30
    • (주)에스.앤.디
    • 여경목최상원권상오김복남김동희
    • A61K31/4045A61K31/135A61K36/286A61K36/906
    • A61K31/4045A61K31/12A61K31/165A61K36/286A61K36/906A61K2300/00
    • PURPOSE: A complex crude drug extract containing a phenylamide compound is provided to prevent and treat hyperlipidemia without side effects and toxicity. CONSTITUTION: A complex crude drug extract for treating hyperlipidemia contains a serotonin derivative, a tyramine derivative, and gingerol in a weight ratio of 5:1:1. The serotonin derivative is N-(p-coumaroyl)serotonin(CS), N-feruloylserotonin(FS), or a mixture thereof. The tyramine derivative is dihydro-N-cafferoyltyramine(DCT), trans-N-cafferoyltyramine(t-CT), or a mixture thereof. Gingerol includes 6-gingerol, 8-gingerol, or a mixture thereof. [Reference numerals] (AA) Ginger + Safflower seed; (BB) Ginger 1 : Safflower seed B8; (CC) Ginger 1 : Safflower seed B4; (DD) Ginger 1 : Safflower seed B2; (EE) Ginger 1 : Safflower seed B1; (FF) Ginger 2 : Safflower seed B1; (GG) Ginger 4 : Safflower seed B1; (HH) Ginger 8 : Safflower seed B1; (II) Ginger 1 : Safflower seed A1; (JJ) Ginger 2 : Safflower seed A1; (KK) Ginger 4 : Safflower seed A1; (LL) Ginger 8 : Safflower seed A1
    • 目的:提供含有苯酰胺化合物的复合生物药物提取物,用于预防和治疗高脂血症,无副作用和毒性。 构成:用于治疗高脂血症的复杂生药提取物含有重量比为5:1:1的5-羟色胺衍生物,酪胺衍生物和姜油。 5-羟色胺衍生物是N-(对 - 香豆酰基)5-羟色胺(CS),N-亚铁血清素(FS)或其混合物。 酪胺衍生物是二氢-N-咖啡酰基酪氨酸(DCT),反式N-咖啡酰酪胺(t-CT)或其混合物。 姜醇包括6-姜醇,8-姜醇或其混合物。 (标号)(AA)姜+红花种子; (BB)姜1:红花种子B8; (CC)姜1:红花籽B4; (DD)姜1:红花籽B2; (EE)姜1:红花籽B1; (FF)姜2:红花籽B1; (GG)姜4:红花籽B1; (HH)姜8:红花籽B1; (二)姜1:红花籽A1; (JJ)姜2:红花籽A1; (KK)姜4:红花籽A1; (LL)姜8:红花籽A1
    • 5. 发明公开
    • 천연물 유래 당 배합체를 이용한 위염 및 암 예방 조성물과 그 제조방법
    • 含有天然提取物的胃肠病和胃癌组合物及其制造方法
    • KR1020140052264A
    • 2014-05-07
    • KR1020120118186
    • 2012-10-24
    • (주)에스.앤.디
    • 여경목권상오함기백김은희이응주김동희
    • A61K36/282A61K36/258A61K36/82A61P35/00
    • The present invention relates to a composition to prevent gastritis and cancer containing sugar complex from natural extract and a manufacturing method thereof and, more specifically, to a composition to prevent gastritis and cancer containing herbal extracts selected from Artemisia capillaris, ginseng, and green tea. The manufacturing method for the composition to prevent gastritis and cancer includes an extraction step to put purified water into herbs and extracting herbal extracts; a filtration and concentration step to filter and concentrate the extracted solution; a crystallization step to separate the product into a precipitate and a precipitate filtrate and crystallizing the same; and a dry and pulverization step to dry the crystals separated through the crystallization step and pulverizing the same.
    • 本发明涉及一种预防胃炎的组合物和来自天然提取物的含糖复合物的组合物及其制备方法,更具体地,涉及一种预防胃炎的组合物和含有选自艾蒿,人参和绿茶的草药提取物的癌症。 用于预防胃炎和癌症的组合物的制备方法包括将纯化水放入草药中并提取草药提取物的提取步骤; 过滤和浓缩步骤以过滤并浓缩提取的溶液; 将产物分离成沉淀物和沉淀滤液并使其结晶的结晶步骤; 以及干燥和粉碎步骤以干燥通过结晶步骤分离的晶体并粉碎。
    • 6. 发明公开
    • 페닐아마이드 화합물을 유효성분으로 하는 고지혈증 치료용 복합 생약 추출물
    • 用于治疗高脂血症的复杂提取物
    • KR1020130025421A
    • 2013-03-11
    • KR1020130010580
    • 2013-01-30
    • (주)에스.앤.디
    • 여경목최상원권상오김복남김동희
    • A61K31/4045A61K31/135A61K36/286A61K36/906
    • A61K31/4045A61K31/165A61K36/286A61K36/906A61K2300/00
    • PURPOSE: A complex crude drug extract containing a phenylamide compound is provided to reduce side effects and toxicity, and to treat hyperlipidemia. CONSTITUTION: A complex crude drug extract for treating hyperlipidemia contains a serotonin derivative and a tyramine derivative in a weight ratio of 4:1. The serotonin derivative is N-(p-coumaroyl)serotonin(CS), N-feruloylserotonin(FS), or a mixture thereof. The tyramine derivative is dihydro-N-caffeoyltyramine(DCT), trans-N-caffeoyltyramine(t-CT), or a mixture thereof. [Reference numerals] (AA) Ginger + Safflower seed; (BB) Ginger 1 : Safflower seed B8; (CC) Ginger 1 : Safflower seed B4; (DD) Ginger 1 : Safflower seed B2; (EE) Ginger 1 : Safflower seed B1; (FF) Ginger 2 : Safflower seed B1; (GG) Ginger 4 : Safflower seed B1; (HH) Ginger 8 : Safflower seed B1; (II) Ginger 1 : Safflower seed A1; (JJ) Ginger 2 : Safflower seed A1; (KK) Ginger 4 : Safflower seed A1; (LL) Ginger 8 : Safflower seed A1
    • 目的:提供含有苯酰胺化合物的复合生物药物提取物,以减少副作用和毒性,并治疗高脂血症。 构成:用于治疗高脂血症的复杂生药提取物含有重量比为4:1的5-羟色胺衍生物和酪胺衍生物。 5-羟色胺衍生物是N-(对 - 香豆酰基)5-羟色胺(CS),N-亚铁血清素(FS)或其混合物。 酪胺衍生物是二氢-N-咖啡酰基酪氨酸(DCT),反式N-咖啡酰酪胺(t-CT)或其混合物。 (标号)(AA)姜+红花种子; (BB)姜1:红花种子B8; (CC)姜1:红花籽B4; (DD)姜1:红花籽B2; (EE)姜1:红花籽B1; (FF)姜2:红花籽B1; (GG)姜4:红花籽B1; (HH)姜8:红花籽B1; (二)姜1:红花籽A1; (JJ)姜2:红花籽A1; (KK)姜4:红花籽A1; (LL)姜8:红花籽A1
    • 7. 发明公开
    • 페닐아마이드 화합물을 유효성분으로 하는 고지혈증 치료용 복합 생약 추출물
    • 用于治疗高脂血症的复杂提取物
    • KR1020120115060A
    • 2012-10-17
    • KR1020110071839
    • 2011-07-20
    • (주)에스.앤.디
    • 여경목최상원권상오김복남김동희
    • A61K36/286A61K36/906A61P3/06
    • PURPOSE: A complex crude drug extract for treating hyperlipidemia which contains phenyl amide compound is provided to show HMG-CoR inhibition effects and ACAT inhibition effects related to treat and prevent the hyperlipidemia. CONSTITUTION: A complex crude drug extract for treating hyperlipidemia is composed of multiple extract of safflower seed and ginger. The mixing ratio of the safflower seed to ginger is 4:1 in the weight ratio. The Lycii Radicis Cortex extract is additionally added to the extract. The mixing ration of the safflower seed, ginger extract, and the Lycii Radicis Cortex extract is 5:1:1 in the weight ratio. The complex crude drug extract for treating hyperlipidemia is composed of serotonin derivative and tyramine derivative. The mixing ratio of serotonin derivative to the tyramine derivative is 4: 1 in the weight ratio. The serotonin derivative is a mixture of N-(p-coumaroyl) serotonin(CS), N- feruloylserotonin(FS), or a mixture thereof. [Reference numerals] (AA) Ginger+safflower seed; (BB) Ginger 1 : Safflower seed B3; (CC) Ginger 1 : Safflower seed B4; (DD) Ginger 1 : Safflower seed B2; (EE) Ginger 1 : Safflower seed B1; (FF) Ginger 2 : Safflower seed B1; (GG) Ginger 4 : Safflower seed B1; (HH) Ginger 8 : Safflower seed B1; (II) Ginger 1 : Safflower seed A1; (JJ) Ginger 2 : Safflower seed A1; (KK) Ginger 4 : Safflower seed A1; (LL) Ginger 8 : Safflower seed A1
    • 目的:提供一种用于治疗含有苯酰胺化合物的高脂血症的复合生药提取物,以显示与治疗和预防高脂血症相关的HMG-CoR抑制作用和ACAT抑制作用。 构成:用于治疗高脂血症的复方生药提取物由红花种子和姜的多次提取物组成。 红花种子与姜的混合比例为4:1。 提取物中还加入Lycii Radicis Cortex提取物。 红花种子,姜提取物和堇菜提取物的混合比例为5:1:1。 用于治疗高脂血症的复方生药提取物由5-羟色胺衍生物和酪胺衍生物组成。 5-羟色胺衍生物与酪胺衍生物的混合比例为重量比为4:1。 5-羟色胺衍生物是N-(对 - 香豆酰基)5-羟色胺(CS),N-阿魏酰基血清素(FS)或其混合物的混合物。 (标号)(AA)姜+红花种子; (BB)姜1:红花籽B3; (CC)姜1:红花籽B4; (DD)姜1:红花籽B2; (EE)姜1:红花籽B1; (FF)姜2:红花籽B1; (GG)姜4:红花籽B1; (HH)姜8:红花籽B1; (二)姜1:红花籽A1; (JJ)姜2:红花籽A1; (KK)姜4:红花籽A1; (LL)姜8:红花籽A1